Ibrutinib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
Clinical trial NCT02219737 · COMPLETED
Trial details
- NCT number
- NCT02219737
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-12
- Primary completion
- 2017-05-11
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.